title: Use of recombinant factor VIIa (Novoseven) in combination with other coagulation products led to a thrombotic occlusion of the truncus brachiocephalicus in a neonate supported by extracorporal membrane oxygenation.
authors.affiliation: *Department of Anaesthesia and Intensive Care Medicine †Department of Pathology ‡Department of Pediatrics; Innsbruck Medical University; Innsbruck, Austria; corinna.velik@uibk.ac.at.
authors.forename: Corinna
authors.initials: C
authors.lastname: Velik-Salchner
authors.forename: Consolato
authors.initials: C
authors.lastname: Sergi
authors.forename: Dietmar
authors.initials: D
authors.lastname: Fries
authors.forename: Patrizia
authors.initials: P
authors.lastname: Moser
authors.forename: Werner
authors.initials: W
authors.lastname: Streif
authors.forename: Christian
authors.initials: C
authors.lastname: Kolbitsch
mesh_terms: D001916:Brachial Artery; D015199:Extracorporeal Membrane Oxygenation; D015942:Factor VIIa / Q000009:adverse effects* / Q000627:therapeutic use; D017809:Fatal Outcome; D005260:Female; D006487:Hemostasis; D006801:Humans; D007231:Infant, Newborn; D011994:Recombinant Proteins / Q000009:adverse effects / Q000627:therapeutic use; D013348:Subclavian Artery; D013927:Thrombosis / Q000139:chemically induced*
chemical_list: D011994:Recombinant Proteins; D015942:Factor VIIa